This is a working overview of lyophilized powder, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2025-12-11 and is reviewed periodically as new material appears.
Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
| Property | Value | Notes |
|---|---|---|
| Typical storage temperature | -20 °C | Lyophilized peptide; protect from moisture and light. |
| Typical analytical method | HPLC and mass spectrometry | Used to confirm identity and estimate purity. |
| Common synonyms | AOD9604; hGH 176-191 | Naming varies by supplier and publication. |
| Disulfide bonds | One | Affects folded structure and stability. |
| Typical research purity | ≥95% | Value depends on supplier and analytical method. |
Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.
AOD-9604 has been investigated primarily as a potential treatment for obesity and related metabolic conditions. Early laboratory work examined its effects on fat cells, and later studies moved into animal models and human clinical trials. Some trials reportedly reached Phase II, but the program did not lead to an approved medicine. Published summaries often note that weight-loss results were modest or inconsistent. The full trial data are not all publicly available in detail.
Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.
A study to test whether a new treatment has an effect (NCI) Controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks. (NLM) Phase 2 includes the controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in patients with the disease or condition under study and to determine the common short-term side effects and risks associated with the drug. Phase 2 studies are typically well controlled, closely monitored, and conducted in a relatively small number of patients, usually involving no more than several hundred subjects. (21CFR312) Phase II/III trial
In spite of the Amazon "Soy Moratorium", soy production continues to play a significant role in deforestation when its indirect impacts are taken into account, as land used to grow soy continues to increase. This land either comes from pasture land (which increasingly supplants forested areas), or areas outside the Amazon not covered by the moratorium, such as the Cerrado region. Roughly one-fifth of deforestation can be attributed to expanding land use to produce oilseeds, primarily for soy and palm oil, whereas the expansion of beef production accounts for 41%. The main driver of deforestation is the global demand for meat, which in turn requires huge tracts of land to grow feed crops for livestock. Around 80% of the global soybean crop is used to feed livestock.
== Animal studies == Mice whose paternally inherited GRB10 gene is inactivated are more aggressive while those whose maternally inherited allele is inactivated exhibit foetal overgrowth and are significantly bigger than wild-type litter-mates.
=== Natural abundance === Although it is rare on Earth, helium is the second most abundant element in the known Universe, constituting 23% of its baryonic mass. Only hydrogen is more abundant. The vast majority of helium was formed by Big Bang nucleosynthesis one to three minutes after the Big Bang. As a result, measurements of its abundance contribute to cosmological models. The first molecular bonds were formed when primordial helium atoms combined with protons to form helium hydride ions, HeH+. In stars, helium is formed by the nuclear fusion of hydrogen in proton–proton chain reactions and the CNO cycle, part of stellar nucleosynthesis. In the Earth's atmosphere, the concentration of helium by volume is only 5.2 parts per million. The concentration is low and fairly constant despite the continuous production of new helium because most helium in the Earth's atmosphere escapes into space by several processes. In the Earth's heterosphere, a part of the upper atmosphere, helium and hydrogen are the most abundant elements. Most helium on Earth is a result of radioactive decay. Helium is found in large amounts in minerals of uranium and thorium, such as uraninite and its varieties cleveite and pitchblende, as well as carnotite and monazite (a group name; "monazite" usually refers to monazite-(Ce)), because they emit alpha particles (helium nuclei, He2+) to which electrons immediately combine as soon as the particle is stopped by the rock. In this way an estimated 3000 metric tons of helium are generated per year throughout the lithosphere.
Sources: en.wikipedia.org
3-Phosphoglyceric acid (3PG, 3-PGA, or PGA) is the conjugate acid of 3-phosphoglycerate or glycerate 3-phosphate (GP or G3P). This glycerate is a biochemically significant metabolic intermediate in both glycolysis and the Calvin-Benson cycle. The anion is often termed as PGA when referring to the Calvin-Benson cycle. In the Calvin-Benson cycle, 3-phosphoglycerate is typically the product of the spontaneous scission of an unstable 6-carbon intermediate formed upon CO2 fixation. Thus, two equivalents of 3-phosphoglycerate are produced for each molecule of CO2 that is fixed. In glycolysis, 3-phosphoglycerate is an intermediate following the dephosphorylation (reduction) of 1,3-bisphosphoglycerate.
Because the Apollo 13 Moon landing was aborted, its RTG rests in the South Pacific Ocean, in the vicinity of the Tonga Trench. The Curiosity and Perseverance Mars rover designs selected RTGs to allow greater flexibility in landing sites and longer lifespan than the solar-powered option, as used in prior generations of rovers. RTGs were also used for the Nimbus, Transit and LES satellites. By comparison, only a few space vehicles have been launched using full-fledged nuclear reactors: the Soviet RORSAT series and the American SNAP-10A. In addition to spacecraft, the Soviet Union built 1,007 RTGs to power uncrewed lighthouses and navigation beacons on the Soviet Arctic coast by the late 1980s. Many different types of RTGs (including Beta-M type) were built in the Soviet Union for a wide variety of purposes. The lighthouses were not maintained for many years after the dissolution of the Soviet Union in 1991. Some of the RTG units disappeared during this time—either by looting or by the natural forces of ice/storm/sea. In 1996, a project was begun by Russian and international supporters to decommission the RTGs in the lighthouses, and by 2021, all RTGs had been removed. As of 1992, the United States Air Force also used RTGs to power remotely-located Arctic equipment, and the US government has used hundreds of such units to power remote stations globally. Sensing stations for Top-ROCC and SEEK IGLOO radar systems, predominantly located in Alaska, use RTGs.
==== Yopo ==== Snuff trays and tubes similar to those commonly used for yopo were found in the central Peruvian coast dating back to 1200 BC, suggesting that insufflation of Anadenanthera beans is a more recent method of use. Archaeological evidence of insufflation use within the period 500-1000 AD, in northern Chile, has been reported.
== Original == The intricate imagery on the lorica musculata (typical of legates) refers to the Parthian Empire’s restitution of Roman eagle insignia, which had previously been captured from Marcus Licinius Crassus, to Augustus in 20 BC, one of his most significant diplomatic accomplishments. The date of the (hypothetical) bronze original is therefore later than 20 BC. The event detailed on the armor symbolizes the Pax Romana initiated by Rome’s first Emperor. The fact that Augustus is depicted barefooted is intended to be a divine representation, as this was a standard depiction of gods or heroes in classical iconography. The date of the marble copy would presumably fall between that date and Livia's death in AD 29. The statue might have been commissioned by Tiberius, the successor to Augustus, possibly as a gift to his mother Livia (since it was found in her Villa ad Gallinas Albas in the vicinity of the ninth mile-marker of the Via Flaminia, and close to a late imperial gate and aqueduct called Prima Porta) after Augustus' death and in honor of the woman who had campaigned for so long for him to become the next Caesar. This hypothesis is based on the fact that the central reliefs on the heroic cuirass depict the retrieval of Crassus' standards captured by the Parthians, an event in which the young Tiberius himself served as an intermediary with the Parthian king, and which was possibly his greatest service to his adoptive father Augustus.
== Ergothioneine derivatives == Various derivatives of ergothioneine have been reported in the literature, such as S-methyl-ergothioneine or selenium-containing selenoneine. The latter is made using the same biosynthetic pathway as ergothioneine when selenocysteine is present.
Sources: en.wikipedia.org
The International Broadcast Center (IBC) was located at the Kay Bailey Hutchison Convention Center in Dallas. Bell Media constructed a broadcast studio at Jack Poole Plaza in Vancouver for the tournament (mirroring an arrangement used by Fox during the 2015 FIFA Women's World Cup), which originated TSN/CTV's coverage from June 11 through July 7 (the final match played in the city). On January 8, 2026, FIFA signed a deal to make TikTok a "preferred platform" for World Cup video content. As part of the agreement, broadcasters could stream parts of matches at a dedicated hub on the TikTok app. FIFA then made a similar "preferred platform" deal with YouTube on March 17, allowing broadcasters to stream select matches in full on their respective YouTube channels, as well as stream the first 10 minutes of every match on the platform as "an appetizer encouraging young fans then to watch on traditional channels". A number of internet content creators were also involved in coverage of the tournament; in Brazil, Casimiro Miguel's CazéTV renewed its digital rights to the World Cup in Brazil, streaming all matches on its YouTube channel. American influencer IShowSpeed conducted streams from matches during the tournament, and later reached an agreement with Fox Sports to offer altcasts of selected matches on Fox One and its YouTube channel featuring his streams combined with the Fox telecasts.
=== Stoichiometry and metabolic cost in cell === The table below lists the abundance of amino acids in E.coli cells and the metabolic cost (ATP) for synthesis of the amino acids. Negative numbers indicate the metabolic processes are energy favorable and do not cost net ATP of the cell. The abundance of amino acids includes amino acids in free form and in polymerization form (proteins).
Fish maw (Chinese: 魚肚, yúdǔ; Yue Chinese: 花胶, fa kau; Mandarin Chinese: 花膠, huājiāo) or "sea ginseng" is a delicacy in Chinese cuisine, particularly Zhejiang cuisine. Consumption of fish maw in China may go back to the Han Dynasty, c. 206 BCE-220 CE. The History of the Southern Dynasties documents fish maw soaked in honey being served in royal court during the Northern and Southern dynasties period, c. 420-589 CE. Consumption of rockfish fish maw was documented in the 6th century Qimin Yaoshu. Fish maw is one of the four sea delicacies of Chinese cuisine, along with abalone, sea cucumber, and shark's fin. Fish maw from larger fish species is more prestigious; the restaurant trade buys smaller maw. Fish maw from male fish is preferred for its relative thickness and resilience to dissolving. Until the late 20th century, the Chinese bahaba or giant yellow croaker Bahaba taipingensis of the China Seas was the premier source of fish maw. However, overfishing has driven the Chinese bahaba population to near-extinction, and raised demand for similar fish, particular the related Sciaenidae. Fish maw, particularly of rare fish, is highly valued in traditional Chinese medicine. TCM practitioners recommend fish maw for the post-partum period and recovering from surgery. It is also valued as a cosmetic: its high level of collagen is believed to improve one's skin. As of 2016, Southern China and Hong Kong had the largest demand for fish maw.
== Cause == Aside from L. odoratus, other members of the genus are also known to cause the disease, including L. sylvestris, L. cicera, and L. clymenum. L. odoratus grows well under famine conditions, often severe drought, where it is cultivated. These legumes carry a variety of osteolathyrogenic compounds, specifically excitatory amino-compounds. The most widely studied of these compounds is beta-aminopropionitrile (BAPN), which exerts its deleterious effect by an unknown yet potently irreversible mechanism. Other instigators are ureides, semicarbazides and thiosemicarbazides, which are believed to chelate the prosthetic Cu(II)-bipyridine cofactor complex in the enzyme lysyl oxidase. Lysyl oxidase is an important enzyme for the creation of crosslinks between collagen triple-helices in connective tissue. By oxidizing the terminal amino group of lysine, an aldehyde is created. This aldehyde can undergo several reactions with neighboring aldehydes or amines to create strong covalent cross-links between collagen tertiary structures in bone and cartilage. The main product of these reactions is the aldimine compound dehydrohydroxylysinonorleucine. This unique crosslink can be formed by the Schiff base mechanism in which the lone pair of electrons on a primary amine react with the carbonyl carbon of an aldehyde. Other crosslinks include the formation of an α,β-unsaturated ketone via aldol condensation and hydroxylysinonorleucine. If these crosslinks are not formed, as in the case of osteolathyrism, the synthesis of strong mesenchymal and mesodermal tissue is inhibited.
Sources: en.wikipedia.org
No. Major drug regulators have not approved AOD-9604 for weight loss or any other therapeutic indication. It remains an investigational compound studied in research settings.
The World Anti-Doping Agency classifies it as a prohibited peptide hormone. Athletes under anti-doping rules are not permitted to use it. Its presence can trigger a doping violation.
It is a fragment of growth hormone rather than a substance that signals the pituitary to release more hormone. Studies have not shown a consistent rise in IGF-1 or full growth hormone. Its metabolic effects, if any, appear separate from those of the complete hormone.
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.